Mutual Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Mutual Advisors, LLC

$3.5 Billion
Q3 2024

A detailed history of Mutual Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mutual Advisors, LLC holds 3,710 shares of VRTX stock, worth $1.67 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,710

Previous 3,689 0.57%

Holding current value

$1.67 Million

Previous $1.73 Million 0.23%

% of portfolio

0.05%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$460.0 - $505.78 $9,660 - $10,621	21 Added 0.57%	3,710 $1.73 Million
Q2 2024 Jul 30, 2024	BUY	$392.81 - $485.53 $170,086 - $210,234	433 Added 13.3%	3,689 $1.73 Million
Q1 2024 May 02, 2024	SELL	$407.69 - $446.08 $26,092 - $28,549	-64 Reduced 1.93%	3,256 $1.36 Million
Q4 2023 Jan 12, 2024	BUY	$343.0 - $410.68 $92,953 - $111,294	271 Added 8.89%	3,320 $1.35 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $27,054 - $28,996	-80 Reduced 2.56%	3,049 $1.06 Million
Q2 2023 Jul 31, 2023	BUY	$314.42 - $351.91 $53,765 - $60,176	171 Added 5.78%	3,129 $1.1 Million
Q1 2023 Apr 11, 2023	SELL	$283.23 - $323.1 $24,924 - $28,432	-88 Reduced 2.89%	2,958 $931,000
Q4 2022 Jan 12, 2023	SELL	$285.76 - $321.48 $7,715 - $8,679	-27 Reduced 0.88%	3,046 $0
Q3 2022 Nov 03, 2022	SELL	$273.83 - $305.53 $96,935 - $108,157	-354 Reduced 10.33%	3,073 $890,000
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $939 - $1,170	-4 Reduced 0.12%	3,427 $966,000
Q1 2022 May 09, 2022	BUY	$221.42 - $260.97 $10,628 - $12,526	48 Added 1.42%	3,431 $895,000
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $26,020 - $32,847	147 Added 4.54%	3,383 $743,000
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $362 - $405	2 Added 0.06%	3,236 $587,000
Q2 2021 Aug 12, 2021	BUY	$187.49 - $221.1 $431,227 - $508,530	2,300 Added 246.25%	3,234 $652,000
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $193,356 - $225,383	934 New	934 $201,000
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $564,475 - $669,244	-2,208 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$225.48 - $295.8 $497,859 - $653,126	2,208 New	2,208 $641,000
Q1 2020 May 13, 2020	SELL	$199.77 - $247.81 $220,745 - $273,830	-1,105 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$166.71 - $223.91 $184,214 - $247,420	1,105 New	1,105 $242,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Advisors, LLC with notifications on news.

Account

Mutual Advisors, LLC Vertex Pharmaceuticals Inc Transaction History